PTN Palatin Technologies Inc

Palatin Technologies Inc is a biopharmaceutical company engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical need and commercial potential.

$0.78
As of 02/26/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
08/07/2001
230,034,307
8,737,071
$188,628,132
0.00%
SEC Edgar Online
10-Q
10-K
696077403
US6960774031
2103781

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-7.09
2.78
-261.81
-39.23%
3,693.92%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy